Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Floor J Backes

Showing results (61-70 of 110) with videos related to

Pageof 11
Sort By:
Cancers|May 14, 2022
A Novel Estrogen Receptor β Agonist Diminishes Ovarian Cancer Stem Cells via Suppressing the Epithelial-to-Mesenchymal TransitionAnanya Banerjee, Shurui Cai, Guozhen Xie, et al.
Gynecologic Oncology|October 8, 2013
Reducing readmissions after robotic surgical management of endometrial cancer: a potential for improved quality careMargaret I Liang, Maggie A Rosen, Kellie S Rath, et al.
Gynecologic Oncology|February 15, 2011
Addition of bevacizumab to weekly paclitaxel significantly improves progression-free survival in heavily pretreated recurrent epithelial ovarian cancerDavid M O'Malley, Debra L Richardson, Patrick S Rheaume, et al.
Gynecologic Oncology|January 30, 2013
Neuroendocrine carcinoma of the uterine cervix: the role of multimodality therapy in early-stage diseaseGeorgia A McCann, Christina E Boutsicaris, Megan M Preston, et al.
Gynecologic Oncology|August 2, 2014
Does intra-operative radiation at the time of pelvic exenteration improve survival for patients with recurrent, previously irradiated cervical, vaginal, or vulvar cancer?Floor J Backes, Caroline C Billingsley, Douglas D Martin, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 25, 2014
Gynecologic Cancer Intergroup (GCIG) consensus review for ovarian germ cell tumorsJubilee Brown, Michael Friedlander, Floor J Backes, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|July 15, 2014
Imaging across the life span: innovations in imaging and therapy for gynecologic cancerMeng Xu-Welliver, William T C Yuh, Julia R Fielding, et al.
Gynecologic Oncology Reports|April 21, 2023
Recurrence rate in early-stage epithelial ovarian cancer: Is there a role for upfront maintenance with PARP inhibitors in stages I and II?Monica D Levine, David M O'Malley, Paulina J Haight, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2024
Bridging the Gap from Bench to Bedside: A Call for In Vivo Preclinical Models to Advance Endometrial Cancer and Cervical Cancer Immuno-oncology ResearchLaura Chambers, Paulina Haight, Julia Chalif, et al.
Journal of Minimally Invasive Gynecology|January 10, 2015
Predicting inpatient stay lasting 2 midnights or longer after robotic surgery for endometrial cancerMargaret I Liang, Maggie A Rosen, Kellie S Rath, et al.
Pageof 11

Showing results (61-70 of 110) with videos related to

Sort By:
Pageof 11
Cancers|May 14, 2022
A Novel Estrogen Receptor β Agonist Diminishes Ovarian Cancer Stem Cells via Suppressing the Epithelial-to-Mesenchymal TransitionAnanya Banerjee, Shurui Cai, Guozhen Xie, et al.
Gynecologic Oncology|October 8, 2013
Reducing readmissions after robotic surgical management of endometrial cancer: a potential for improved quality careMargaret I Liang, Maggie A Rosen, Kellie S Rath, et al.
Gynecologic Oncology|February 15, 2011
Addition of bevacizumab to weekly paclitaxel significantly improves progression-free survival in heavily pretreated recurrent epithelial ovarian cancerDavid M O'Malley, Debra L Richardson, Patrick S Rheaume, et al.
Gynecologic Oncology|January 30, 2013
Neuroendocrine carcinoma of the uterine cervix: the role of multimodality therapy in early-stage diseaseGeorgia A McCann, Christina E Boutsicaris, Megan M Preston, et al.
Gynecologic Oncology|August 2, 2014
Does intra-operative radiation at the time of pelvic exenteration improve survival for patients with recurrent, previously irradiated cervical, vaginal, or vulvar cancer?Floor J Backes, Caroline C Billingsley, Douglas D Martin, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 25, 2014
Gynecologic Cancer Intergroup (GCIG) consensus review for ovarian germ cell tumorsJubilee Brown, Michael Friedlander, Floor J Backes, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|July 15, 2014
Imaging across the life span: innovations in imaging and therapy for gynecologic cancerMeng Xu-Welliver, William T C Yuh, Julia R Fielding, et al.
Gynecologic Oncology Reports|April 21, 2023
Recurrence rate in early-stage epithelial ovarian cancer: Is there a role for upfront maintenance with PARP inhibitors in stages I and II?Monica D Levine, David M O'Malley, Paulina J Haight, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2024
Bridging the Gap from Bench to Bedside: A Call for In Vivo Preclinical Models to Advance Endometrial Cancer and Cervical Cancer Immuno-oncology ResearchLaura Chambers, Paulina Haight, Julia Chalif, et al.
Journal of Minimally Invasive Gynecology|January 10, 2015
Predicting inpatient stay lasting 2 midnights or longer after robotic surgery for endometrial cancerMargaret I Liang, Maggie A Rosen, Kellie S Rath, et al.
Pageof 11